The United States Food and Drug Administration (FDA) has approved FYB203/Ahzantive (aflibercept-mrbb), a biosimilar to Eylea developed by Formycon.
Optometrists in Sydney and surrounds are invited to attend Eyecare Social, a unique CPD event hosted by WorkRex and Aelo in Surry Hills on
Optometrists interested in expanding their knowledge of orthokeratology are invited to attend an interactive masterclass hosted by the Australian College of Optometry (ACO) in
After an extensive global search, Professor Peter van Wijngaarden has been named as the next Director and CEO of The Florey Institute of Neuroscience
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
